z-logo
open-access-imgOpen Access
Screening and identification of insertion mutants from B ipolaris eleusines by mutagenesis based on restriction enzyme‐mediated integration
Author(s) -
Jianping Zhang,
Guifang Duan,
Kai Zhu,
Yongjun Zhou,
Yongliang Lu,
Liuqing Yu
Publication year - 2012
Publication title -
fems microbiology letters
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.899
H-Index - 151
eISSN - 1574-6968
pISSN - 0378-1097
DOI - 10.1111/j.1574-6968.2012.02537.x
Subject(s) - transformation (genetics) , biology , plasmid , mutant , phytotoxin , transposon mutagenesis , microbiology and biotechnology , mutagenesis , mycelium , gene , wild type , biochemistry , toxin , transposable element , botany
Ophiobolin A is sesterterpenoid‐type phytotoxin and may be an important candidate for development of new crop protection and pharmaceutical products. The restriction enzyme‐mediated integration ( REMI ) method was used to introduce the plasmid pSH 75 into the ophiobolin A ‐producing filamentous fungus B ipolaris eleusines . A total of 323 stable transformants were obtained, all of which were capable of growing on potato‐dextrose agar medium containing 200 μg  mL −1 hygromycin B . The transformation frequency was about 4–5 transformants μg −1 plasmid DNA . An ophibolin A ‐deficient transformant ( B 014) was assessed and the presence of the hph gene in this transformant was confirmed by PCR . The cell‐free cultural filtrates of this transformant showed significantly less inhibition on mycelial growth of the fungal pathogen R hizoctoni solani but little effect on barnyard grass as opposed to that of the wild‐type B . eleusines . There was no detectable amount of ophiobolin A in B 014 samples measured with HPLC . This research suggests REMI as a potential approach for improving the production of ophiobolin A by B . eleusines via genetic engineering to upregulate certain genes responsible for desired biosynthetic pathways.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here